Search Ontology:
ChEBI

efavirenz

Term ID
CHEBI:119486
Synonyms
  • (-)-6-CHLORO-4-CYCLOPROPYLETHYNYL-4-TRIFLUOROMETHYL-1,4-DIHYDRO-2H-3,1-BENZOXAZIN-2-ONE
  • (4S)-6-chloro-4-(cyclopropylethynyl)-4-(trifluoromethyl)-1,4-dihydro-2H-3,1-benzoxazin-2-one
  • (S)-6-chloro-4-(cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)-2H-3,1-benzoxazin-2-one
  • (S)-6-chloro-4-cyclopropylethynyl-4-trifluoromethyl-1,4-dihydro-benzo[d][1,3]oxazin-2-one
  • 6-chloro-4-(2-cyclopropyl-1-ethynyl)-4-trifluoromethyl-(4S)-1,4-dihydro-2H-benzo[d][1,3]oxazin-2-one
  • Efavirenz
Definition
1,4-Dihydro-2H-3,1-benzoxazin-2-one substituted at the 4 position by cyclopropylethynyl and trifluoromethyl groups (S configuration) and at the 6 position by chlorine. A non-nucleoside reverse transcriptase inhibitor with activity against HIV, it is used with other antiretrovirals for combination therapy of HIV infection.
References
  • cas:154598-52-4
  • drugbank:DB00625
  • drugcentral:989
  • hmdb:HMDB0014763
  • kegg.compound:C08088
  • kegg.drug:D00896
  • lincs.smallmolecule:LSM-5526
  • patent:EP582455
  • patent:US5519021
  • pdb-ccd:EFZ
  • pubmed:10576692
  • pubmed:10673109
  • pubmed:25017682
  • reaxys:7387333
  • wikipedia.en:Efavirenz
Ontology
ChEBI  ( EBI )
Relationships
Phenotype
Phenotype resulting from efavirenz
Phenotype where environments contain efavirenz
Phenotype modified by environments containing efavirenz
Phenotype affecting efavirenz
Human Disease Model